![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) University of Pennsylvania |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00000356 |
The purpose of this study is to determine the pharmacokinetics of L-alpha-acetylmethadol (LAAM) in adults transferred from methadone maintenance treatment for opiate dependence.
Condition | Intervention | Phase |
---|---|---|
Opioid-Related Disorders Substance-Related Disorders |
Drug: LAAM |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment |
Official Title: | Pharmacokinetics of LAAM in Methadone Patients |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Please contact site for information.
United States, Pennsylvania | |
University of Pennsylvania | |
Philadelphia, Pennsylvania, United States, 19104 6178 |
Principal Investigator: | Charles O'Brien, M.D., Ph.D. | PDVAMC Treatment Research Center |
Study ID Numbers: | NIDA-3-0012-5, Y01-3-0012-5 |
Study First Received: | September 20, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00000356 |
Health Authority: | United States: Federal Government |
Methadyl Acetate Methadone Mental Disorders |
Substance-Related Disorders Disorders of Environmental Origin Opioid-Related Disorders |
Pathologic Processes Disease |